We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s proposed plan for spending the $500 million allocated by the 21st Century Cures Act through fiscal 2025 prioritizes patient-focused drug development, qualification of biomarkers, and the use of real-world evidence. Read More
The U.K.’s Medicines and Healthcare products Regulatory Agency laid out its top 10 priorities for 2017 and 2018 — including ensuring GMP compliance and quality throughout supply chains. Read More
The Senate on Thursday approved the House version of a spending bill for fiscal 2017 in a 79-18 vote — including a modest increase in FDA funds through September. The president was expected to sign the bill into law quickly. Read More
With a 309-118 vote, the U.S. House approved a bill Wednesday that would boost FDA funding and keep the government running through the end of the fiscal year. Read More